GlaxoSmithkline Pharmaceuticals Ltd (GLAX)

Currency in INR
2,727.60
+14.20(+0.52%)
Closed·
Advertisement
GLAXO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,680.002,748.00
52 wk Range
2,088.103,120.70
Key Statistics
Bid/Ask
2,727.60 / 2,745.00
Prev. Close
2,727.6
Open
2,701
Day's Range
2,680-2,748
52 wk Range
2,088.1-3,120.7
Volume
84.48K
Average Volume (3m)
91.19K
1-Year Change
9.1957%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLAXO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
ICICI Securities
Buy2,900.00+6.32%-Upgrade06/11/2026
Bernstein SocGen Group
Buy3,430.00+25.75%-New Coverage04/11/2026
ICICI Securities
Buy2,900.00+6.32%2,725.00Maintain04/08/2026
ICICI Securities
Buy2,725.00-0.10%2,850.00Maintain15/05/2026

Earnings

Latest Release
03/11/2026
EPS / Forecast
19.80 / --
Revenue / Forecast
11.84B / 10.79B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 67.85
Dividend Yield
2.10%
Industry Median 0.63%
Annualised payout
57.00
Paid unevenly
5-Years Growth
+13.70%
Growth Streak

Compare GLAXO to Peers and Sector

Metrics to compare
GLAXO
Peers
Sector
Relationship
P/E Ratio
40.4x33.5x−0.2x
PEG Ratio
1.991.070.00
Price/Book
24.6x8.1x2.6x
Price / LTM Sales
11.1x6.1x2.6x
Upside (Analyst Target)
15.4%14.9%77.0%
Fair Value Upside
Unlock6.3%13.7%Unlock

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease; and Seretide. In addition, the company offers general medicines, including Augmentin, an oral antibiotic for respiratory tract infections, surgical prophylaxis, dental infections, and skin infections; Ceftum, an anti-infective medicine; Calpol and Calpol T for pain management; Eltroxin for the treatment of hypothyroidism; Neosporin, Betnovate, T-bact, Physiogel, Tenovate, and Flutivate for dermatology indications; and CobadexCZS and CCM, which are mineral, vitamins, and nutrition products. Further, it provides oncology medicines, including Jemperli and Zejula. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. The company was incorporated in 1924 and is headquartered in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.

Employees
3103
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14.27M8.42%38.91B
Other Institutional Investors
133.59M78.86%364.39B
Public Companies & Retail Investors
21.55M12.72%58.77B
Total
169.41M100.00%462.07B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
GSK plc75.00%127,054,524346,553,920
Aditya Birla Sun Life AMC Limited1.28%2,168,3975,914,520

People Also Watch

3,331.90
GLAD
+1.18%
3,781.00
BSEL
+0.42%
30,150.00
HITN
-1.95%
3,206.00
SUPI
-0.08%

FAQ

What Is the GSK Pharms (NSE: GLAXO) Share Price Today?

The GSK Pharms stock price today is 2,727.60 INR.

What Stock Exchange Does GSK Pharms (GLAXO) Trade On?

GSK Pharms is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for GSK Pharms?

The stock symbol (also called a 'ticker') for GSK Pharms is "GLAXO."

Does GSK Pharms Pay Dividends? What’s The Current GLAXO Dividend Yield?

Yes, GLAXO Pays Dividends to its Shareholders. The current GSK Pharms dividend yield is 2.1%%.

What Is the Current GSK Pharms Market Capitalisation?

As of today, GSK Pharms (NSE: GLAXO) market cap is 462.90B INR.

What Is GSK Pharms's (GLAXO) Earnings Per Share (TTM)?

The GSK Pharms EPS is currently 67.85 (Trailing Twelve Months).

When Is the Next GSK Pharms Earnings Date?

GSK Pharms's next earnings report will be released on 15/02/2027.

Is GLAXO a Buy or Sell From a Technical Analyst Perspective?

Based on today's GSK Pharms moving averages and other technical indicators, the daily buy/sell signal for GLAXO stock is Strong Buy.

How Many Times Has GSK Pharms Stock Split?

GSK Pharms has split 1 times. (See the GLAXO stock split history page for full effective split date and price information.)

How Many Employees Does GSK Pharms Have?

GSK Pharms has 3103 employees, based on their latest Companies House report.

What is the current trading status of GSK Pharms (NSE: GLAXO)?

As of 22/11/2026, GSK Pharms (GLAXO) is trading at a share price of 2,727.60 INR, with a previous close of 2,727.60 INR. The stock has fluctuated within a day range of 2,680.00 INR to 2,748.00 INR, while its 52-week range spans from 2,088.10 INR to 3,120.70 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.